Precigen Inc (PGEN)
1.425
+0.02
(+1.79%)
USD |
NASDAQ |
May 03, 16:00
1.425
0.00 (0.00%)
After-Hours: 16:27
Precigen Free Cash Flow (Quarterly): -16.81M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.81M |
| September 30, 2023 | -17.24M |
| June 30, 2023 | -15.87M |
| March 31, 2023 | -18.54M |
| December 31, 2022 | -15.45M |
| September 30, 2022 | -25.39M |
| June 30, 2022 | -8.771M |
| March 31, 2022 | -20.36M |
| December 31, 2021 | -17.36M |
| September 30, 2021 | -19.29M |
| June 30, 2021 | -8.97M |
| March 31, 2021 | -17.40M |
| December 31, 2020 | -17.94M |
| September 30, 2020 | -20.03M |
| June 30, 2020 | -15.69M |
| March 31, 2020 | -30.90M |
| December 31, 2019 | 52.44M |
| September 30, 2019 | -34.92M |
| June 30, 2019 | -47.30M |
| March 31, 2019 | -54.76M |
| December 31, 2018 | -48.60M |
| September 30, 2018 | -37.58M |
| June 30, 2018 | -38.98M |
| March 31, 2018 | -40.66M |
| Date | Value |
|---|---|
| December 31, 2017 | -47.87M |
| September 30, 2017 | -36.42M |
| June 30, 2017 | -35.06M |
| March 31, 2017 | -31.03M |
| December 31, 2016 | -28.64M |
| September 30, 2016 | -25.89M |
| June 30, 2016 | -18.22M |
| March 31, 2016 | -7.866M |
| December 31, 2015 | 9.424M |
| September 30, 2015 | 49.79M |
| June 30, 2015 | -20.55M |
| March 31, 2015 | -15.75M |
| December 31, 2014 | -10.23M |
| September 30, 2014 | -8.076M |
| June 30, 2014 | -14.42M |
| March 31, 2014 | 6.497M |
| December 31, 2013 | -10.49M |
| September 30, 2013 | -16.33M |
| June 30, 2013 | -13.93M |
| March 31, 2013 | -14.46M |
| December 31, 2012 | -12.68M |
| September 30, 2012 | -15.46M |
| June 30, 2012 | -22.21M |
| March 31, 2012 | -18.67M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-47.30M
Minimum
Jun 2019
52.44M
Maximum
Dec 2019
-16.62M
Average
-17.40M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | -3.91M |
| HealthEquity Inc | 65.80M |
| Corvus Pharmaceuticals Inc | -5.167M |
| Oragenics Inc | -1.102M |
| MAIA Biotechnology Inc | -3.992M |